Stanley-Laman Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.76M | Sell |
97,844
-25,688
| -21% | -$986K | 0.56% | 80 |
|
|
2025
Q1 | $4.79M | Buy |
123,532
+16,313
| +15% | +$632K | 0.74% | 41 |
|
|
2024
Q4 | $3.63M | Sell |
107,219
-23,241
| -18% | -$786K | 0.51% | 84 |
|
|
2024
Q3 | $5.33M | Buy |
130,460
+23,293
| +22% | +$952K | 0.75% | 31 |
|
|
2024
Q2 | $4.13M | Buy |
107,167
+97,578
| +1,018% | +$3.76M | 0.59% | 68 |
|
|
2024
Q1 | $411K | Hold |
9,589
| – | – | 0.06% | 198 |
|
|
2023
Q4 | $355K | Buy |
+9,589
| New | +$355K | 0.05% | 199 |
|
|
2017
Q2 | – | Sell |
-45,129
| Closed | -$2.38M | – | 210 |
|
|
2017
Q1 | $2.38M | Sell |
45,129
-9,116
| -17% | -$480K | 0.64% | 51 |
|
|
2016
Q4 | $2.61M | Buy |
54,245
+30,211
| +126% | +$1.45M | 0.81% | 29 |
|
|
2016
Q3 | $1.3M | Sell |
24,034
-1,278
| -5% | -$68.9K | 0.53% | 45 |
|
|
2016
Q2 | $1.37M | Sell |
25,312
-3,930
| -13% | -$213K | 0.54% | 45 |
|
|
2016
Q1 | $1.48M | Sell |
29,242
-43,300
| -60% | -$2.19M | 0.28% | 88 |
|
|
2015
Q4 | $3.66M | Sell |
72,542
-657
| -0.9% | -$33.1K | 0.63% | 47 |
|
|
2015
Q3 | $3.52M | Sell |
73,199
-2,141
| -3% | -$103K | 0.72% | 41 |
|
|
2015
Q2 | $3.92M | Buy |
75,340
+77
| +0.1% | +$4.01K | 0.72% | 44 |
|
|
2015
Q1 | $4.34M | Buy |
75,263
+5,281
| +8% | +$305K | 0.79% | 44 |
|
|
2014
Q4 | $3.74M | Buy |
69,982
+2,364
| +3% | +$126K | 0.71% | 46 |
|
|
2014
Q3 | $3.89M | Buy |
67,618
+473
| +0.7% | +$27.2K | 0.75% | 40 |
|
|
2014
Q2 | $4.49M | Buy |
67,145
+40
| +0.1% | +$2.67K | 0.82% | 40 |
|
|
2014
Q1 | $4.48M | Buy |
67,105
+9,284
| +16% | +$620K | 0.78% | 42 |
|
|
2013
Q4 | $3.86M | Buy |
+57,821
| New | +$3.86M | 0.84% | 40 |
|